跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BIO-PREGABALIN
Authorized
STANDARD
BIO-PREGABALIN
biomed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
061186a0c05cb92b
Company
biomed pharma
Type
Standard
Approval Details
Approval Id
061186a0c05cb92b
Drug Approval Canada Name
BIO-PREGABALIN
Product Name
BIO-PREGABALIN
Status
Marketed
Status Date
2024-02-29
Original Market Date
2024-02-29
Din
02541122
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N02BF02 PREGABALIN
Atc Name
n 02 bf 02
Aig Number
0151121001
Company Name
biomed pharma
Company Address
1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8
Active Ingredients
PREGABALIN
25 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
061186a0c05cb92b
Type
Standard
Back to Health Canada Approvals
BIO-PREGABALIN - Health Canada Drug Approval Details